Betahistine Tablets IP 8 mg (VENPOBET-8) are used for the effective treatment of Ménière’s disease and associated symptoms such as vertigo, tinnitus, and hearing loss. Betahistine improves microcirculation in the inner ear, helps reduce endolymphatic pressure, and restores balance within the vestibular system, leading to better symptom control. This low-dose 8 mg formulation is ideal for patients requiring gradual dose titration or mild-to-moderate symptom management.
Betahistine 8 mg: A histamine analog that enhances blood flow in the inner ear, reduces fluid pressure, and helps alleviate dizziness, ringing in the ears, and hearing fluctuations.
Manages Vertigo Effectively: Reduces spinning sensations, dizziness, and balance instability.
Relieves Tinnitus & Ear Pressure: Helps reduce ringing in the ears and pressure caused by excess inner ear fluid.
Improves Hearing Clarity: Enhances inner ear circulation and reduces symptoms associated with Ménière’s disease.
Supports Long-Term Vestibular Health: Beneficial for chronic inner ear disorders requiring continuous therapy.
Take orally as prescribed by the physician. Consistent use is recommended for best symptom relief in Ménière’s disease.
May include headache, nausea, stomach discomfort, or bloating. Consult a doctor if symptoms persist or worsen.
Globus Labs brings you WHO-GMP–certified, high-quality Betahistine sourced from reputed pharmaceutical manufacturers. Venpobet-8 is formulated to deliver safe, potent, and clinically trusted support.
Whether you’re seeking a franchise opportunity, exploring wholesale distribution, or evaluating Globus Labs for international trade, we’re here to help you build a strong, profitable partnership. Let’s discuss how we can grow together and create meaningful value for your business.